Perceptive Advisors LLC, 10% Owner at Lyra Therapeutics, Inc. (LYRA), sold 74,472 shares at $3.90 ($294K) on 2025-11-13, disclosed to the SEC on 2025-11-13.
Open-market sale of $294k LYRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.31 | 537 | $2K | 0.8% |
| 2 | $4.31 | 4,783 | $21K | 7.0% |
| 3 | $4.06 | 883 | $4K | 1.2% |
| 4 | $4.06 | 7,862 | $32K | 10.9% |
| 5 | $3.90 | 3,213 | $13K | 4.3% |
| 6 | $3.90 | 28,597 |
| $112K |
| 37.9% |
| 7 | $3.90 | 28,597 | $112K | 37.9% |
| Total | $3.95 avg | 74,472 | $294K | 100% |
| Filing → |
| ACRV | SELL | 2025-04-29 | $5.1M | — | Filing → |
| VRCA | BUY | 2023-12-26 | $3.6M | — | Filing → |
| ATXS | BUY | 2023-12-22 | $4.6M | — | Filing → |